The specific explanation for exclusion criteria were as follows: (3) uncertainty regarding the timing of the initial prescription of oral semaglutide, (4) rapid dose escalation of oral semaglutide during hospitalization, (5) potential confounding effects on HbA1c levels, and (6, 7) difficulties in accurately assessing the therapeutic effects of oral semaglutide
FDA approval is expected in Q4 2026
Interpersonal life stress, inflammation, and depression in adolescence: testing social signal transduction theory of depression
Premium Ipamorelin is a synthetic pentapeptide and a highly selective growth hormone secretagogue (GHS)
After one year for those who discontinued or did not reach the 14 mg dose: adverse effects related to the medication (type, severity) and reason for treatment discontinuation
Studies GLP-1 receptor agonists like Wegovy and Ozempic help with weight loss by reducing appetite and slowing digestion, making dietary choices crucial (Kute et al., 2024)